About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

Identifying COVID-19 disease severity in real-world data: implications for medical product effectiveness studies. 

Pharmacoepidemiology and Drug Safety. 2026

Meningococcal B vaccination patterns across 10 integrated health systems within the Vaccine Safety Datalink, 2015-2023. 

Journal of Pediatrics. 2026

Postmarketing safety surveillance for GSK's AS01(E)-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study. 

BMJ open. 2026

Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the Vaccine Safety Datalink. 

Vaccine. 2025

Risk of arterial and venous thrombotic events among patients with COVID-19: a multi-national collaboration of regulatory agencies from Canada, Europe, and United States. 

Clinical Epidemiology. 2024

Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. 

BMJ Med. 2023

Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients. 

JAMA. 2022

Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data. 

Pharmacoepidemiology and Drug Safety. 2022

Contact

full name

N. M. Cocoros

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science